Vitreoretinopathy
Gene: LRP5
Classified as Definitive by Retina GCEP for AR GDA - they did not curate the AD GDA as they felt that the mechanisms of disease are different hence why they weren’t lumped together. AR appears to be LoF mechanism of disease whilst AD is still under investigation (possibly dominant negative)
AR vitreoretinopathy - https://search.clinicalgenome.org/CCID:005302
PMID: 12172548, 12579474 - AD GDA for vitreoretinopathy
Green assertion with >3 unrelated individuals reported with different variants.Created: 29 Jan 2026, 7:45 p.m. | Last Modified: 29 Jan 2026, 7:45 p.m.
Panel Version: 1.9
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
LRP5-related exudative vitreoretinopathy MONDO:0700228
Publications
Well established gene-disease association.Created: 16 Jan 2021, 8:23 p.m. | Last Modified: 16 Jan 2021, 8:23 p.m.
Panel Version: 0.33
Mode of inheritance
BOTH monoallelic and biallelic, autosomal or pseudoautosomal
Phenotypes
Exudative vitreoretinopathy 4, MIM# 601813
Gene: lrp5 has been classified as Green List (High Evidence).
Phenotypes for gene: LRP5 were changed from to Exudative vitreoretinopathy 4, MIM# 601813
Mode of inheritance for gene: LRP5 was changed from Unknown to BOTH monoallelic and biallelic, autosomal or pseudoautosomal
gene: LRP5 was added gene: LRP5 was added to Vitreoretinopathy. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: LRP5 was set to Unknown